DK1611106T3 - Fremstilling af quinapril hydrochlorid - Google Patents
Fremstilling af quinapril hydrochloridInfo
- Publication number
- DK1611106T3 DK1611106T3 DK04721968T DK04721968T DK1611106T3 DK 1611106 T3 DK1611106 T3 DK 1611106T3 DK 04721968 T DK04721968 T DK 04721968T DK 04721968 T DK04721968 T DK 04721968T DK 1611106 T3 DK1611106 T3 DK 1611106T3
- Authority
- DK
- Denmark
- Prior art keywords
- preparation
- quinapril hydrochloride
- quinapril
- hydrochloride
- Prior art date
Links
- 229960003042 quinapril hydrochloride Drugs 0.000 title 1
- IBBLRJGOOANPTQ-JKVLGAQCSA-N quinapril hydrochloride Chemical compound Cl.C([C@@H](C(=O)OCC)N[C@@H](C)C(=O)N1[C@@H](CC2=CC=CC=C2C1)C(O)=O)CC1=CC=CC=C1 IBBLRJGOOANPTQ-JKVLGAQCSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US45901603P | 2003-03-31 | 2003-03-31 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1611106T3 true DK1611106T3 (da) | 2006-12-27 |
Family
ID=33131855
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK04721968T DK1611106T3 (da) | 2003-03-31 | 2004-03-19 | Fremstilling af quinapril hydrochlorid |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US6858735B2 (da) |
| EP (1) | EP1611106B1 (da) |
| JP (1) | JP2006522092A (da) |
| KR (1) | KR20050115323A (da) |
| CN (1) | CN1747935A (da) |
| AR (1) | AR043949A1 (da) |
| AT (1) | ATE340161T1 (da) |
| AU (1) | AU2004226154B2 (da) |
| BR (1) | BRPI0408924A (da) |
| CA (1) | CA2517451C (da) |
| CL (1) | CL2004000541A1 (da) |
| DE (1) | DE602004002473T2 (da) |
| DK (1) | DK1611106T3 (da) |
| ES (1) | ES2271868T3 (da) |
| MX (1) | MXPA05010498A (da) |
| PL (1) | PL1611106T3 (da) |
| PT (1) | PT1611106E (da) |
| RS (1) | RS20050597A (da) |
| RU (1) | RU2298004C2 (da) |
| TW (1) | TWI284637B (da) |
| WO (1) | WO2004087671A1 (da) |
| ZA (1) | ZA200505214B (da) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009053994A1 (en) * | 2007-10-26 | 2009-04-30 | Matrix Laboratories Limited | Process for preparing pure amorphous quinapril hydrochloride |
| JP6215339B2 (ja) | 2012-11-12 | 2017-10-18 | デピュイ・シンセス・プロダクツ・インコーポレイテッド | 椎体間干渉インプラント及び器具 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
| EP0065301A1 (en) | 1981-05-18 | 1982-11-24 | Merck & Co. Inc. | Isoquinoline carboxylic acid derivates, process for preparing and pharmaceutical composition containing the same |
| US4686295A (en) * | 1982-03-10 | 1987-08-11 | Usv Pharmaceutical Corporation | N-carboxy anhydride intermediates |
| US4761479A (en) * | 1987-03-30 | 1988-08-02 | Warner-Lambert Company | Crystalline quinapril and a process for producing the same |
| ES2122941B1 (es) | 1997-05-29 | 1999-07-01 | Esteve Quimica Sa | Procedimiento para la obtencion de quinapril clorhidrato y solvatos utiles para el aislamiento y purificacion de quinapril clorhidrato. |
| WO2002018321A2 (en) * | 2000-08-29 | 2002-03-07 | Abbott Laboratories | Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
| US6541635B1 (en) * | 2002-03-29 | 2003-04-01 | Everlight Usa, Inc. | Method for producing angiotensin converting enzyme inhibitor |
| EP1572661B1 (en) * | 2002-12-16 | 2007-04-25 | Lupin Limited | Crystalline form of quinapril hydrochloride and process for preparing the same |
-
2004
- 2004-03-16 CL CL200400541A patent/CL2004000541A1/es unknown
- 2004-03-19 DK DK04721968T patent/DK1611106T3/da active
- 2004-03-19 AU AU2004226154A patent/AU2004226154B2/en not_active Ceased
- 2004-03-19 CA CA002517451A patent/CA2517451C/en not_active Expired - Fee Related
- 2004-03-19 MX MXPA05010498A patent/MXPA05010498A/es not_active Application Discontinuation
- 2004-03-19 CN CNA2004800040018A patent/CN1747935A/zh active Pending
- 2004-03-19 EP EP04721968A patent/EP1611106B1/en not_active Expired - Lifetime
- 2004-03-19 BR BRPI0408924-3A patent/BRPI0408924A/pt not_active IP Right Cessation
- 2004-03-19 AT AT04721968T patent/ATE340161T1/de not_active IP Right Cessation
- 2004-03-19 PL PL04721968T patent/PL1611106T3/pl unknown
- 2004-03-19 RS YUP-2005/0597A patent/RS20050597A/sr unknown
- 2004-03-19 RU RU2005130402/04A patent/RU2298004C2/ru not_active IP Right Cessation
- 2004-03-19 JP JP2006506407A patent/JP2006522092A/ja not_active Withdrawn
- 2004-03-19 ES ES04721968T patent/ES2271868T3/es not_active Expired - Lifetime
- 2004-03-19 WO PCT/IB2004/000942 patent/WO2004087671A1/en not_active Ceased
- 2004-03-19 PT PT04721968T patent/PT1611106E/pt unknown
- 2004-03-19 KR KR1020057018421A patent/KR20050115323A/ko not_active Ceased
- 2004-03-19 DE DE602004002473T patent/DE602004002473T2/de not_active Expired - Fee Related
- 2004-03-23 US US10/806,707 patent/US6858735B2/en not_active Expired - Fee Related
- 2004-03-29 AR ARP040101036A patent/AR043949A1/es not_active Application Discontinuation
- 2004-03-30 TW TW093108753A patent/TWI284637B/zh not_active IP Right Cessation
-
2005
- 2005-06-28 ZA ZA200505214A patent/ZA200505214B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR20050115323A (ko) | 2005-12-07 |
| PT1611106E (pt) | 2006-11-30 |
| CA2517451C (en) | 2009-04-21 |
| TWI284637B (en) | 2007-08-01 |
| RS20050597A (sr) | 2007-09-21 |
| EP1611106A1 (en) | 2006-01-04 |
| BRPI0408924A (pt) | 2006-04-04 |
| AR043949A1 (es) | 2005-08-17 |
| AU2004226154A1 (en) | 2004-10-14 |
| ATE340161T1 (de) | 2006-10-15 |
| RU2005130402A (ru) | 2006-02-10 |
| US20040192613A1 (en) | 2004-09-30 |
| ES2271868T3 (es) | 2007-04-16 |
| RU2298004C2 (ru) | 2007-04-27 |
| WO2004087671A1 (en) | 2004-10-14 |
| MXPA05010498A (es) | 2005-11-16 |
| EP1611106B1 (en) | 2006-09-20 |
| DE602004002473T2 (de) | 2007-06-14 |
| JP2006522092A (ja) | 2006-09-28 |
| TW200424177A (en) | 2004-11-16 |
| CA2517451A1 (en) | 2004-10-14 |
| US6858735B2 (en) | 2005-02-22 |
| CN1747935A (zh) | 2006-03-15 |
| DE602004002473D1 (de) | 2006-11-02 |
| ZA200505214B (en) | 2008-08-27 |
| AU2004226154B2 (en) | 2007-03-08 |
| PL1611106T3 (pl) | 2007-01-31 |
| CL2004000541A1 (es) | 2005-02-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3395338T3 (da) | Hurtigt opløsende formulering af cinacalcet-hcl | |
| DK1802579T3 (da) | Derivater af 3-arylaminopyridin | |
| DK1730151T4 (da) | Fremgangsmåde til fremstilling af oxycodonhydrochlorid med mindre end 25 ppm 14-hydroxycodeinon | |
| DK2402005T3 (da) | Formuleringer med langvarig frigivelse af nalbuphin | |
| DK1828164T3 (da) | Fremgangsmåde til fremstilling af N-phenylpyrazol-1-carboxamider | |
| DK1778668T3 (da) | Fremgangsmåde til fremstilling af dihydropteridion | |
| DK2172205T3 (da) | Farmaceutisk formulering bestående af lanthan-forbindelser | |
| DK1575565T3 (da) | Tablet med modificeret frigivelse af bupropion-hydrochlorid | |
| DK1992697T3 (da) | Fremstilling af TNFR-Fc | |
| DK1791820T3 (da) | Enantioselektiv fremstilling af quinolinderivater | |
| DK1778618T3 (da) | Syntese af triethylentetraminer | |
| DK1587542T3 (da) | Anvendelse af anti-CD100-antistoffer | |
| DK1619180T3 (da) | CaSR-antagonist | |
| DK1487840T3 (da) | Krystallinsk polymorf form af irinotecan hydrochlorid | |
| DK1516540T3 (da) | Anvendelse af vitamin D-forbindelser | |
| NO20043305D0 (no) | Preparation of lodixanol | |
| DK1575941T3 (da) | Fremgangsmåde til fremstilling af (S)-pantoprazol | |
| DK1682541T3 (da) | Fremgangsmåde til fremstilling af tiotropiumsalte | |
| DK1831223T3 (da) | Fremgangsmåde til fremstilling af L-biopterin | |
| DK1692137T3 (da) | Fremgangsmåde til fremstilling af tubulinininhibitorer | |
| DK1519936T3 (da) | Fremgangsmåde til fremstilling af nevirapin | |
| DK1654280T3 (da) | Fremstilling af somatostatinpeptider | |
| DK1611106T3 (da) | Fremstilling af quinapril hydrochlorid | |
| DK2253619T3 (da) | Aminsalt af carbostyrilderivat | |
| DK1606246T3 (da) | Fremgangsmåde til fremstilling af 2-cyan-3-hydroxy-N-(phenyl)but-2-enamider |